Unusual presentation of Kaposi sarcoma in an HIV-negative woman by Limmer, Allison L et al.
UC Davis
Dermatology Online Journal
Title
Unusual presentation of Kaposi sarcoma in an HIV-negative woman
Permalink
https://escholarship.org/uc/item/7pz3z82d
Journal
Dermatology Online Journal, 26(4)
Authors
Limmer, Allison L
Park, Katherine E
Patel, Anisha B
et al.
Publication Date
2020
License
https://creativecommons.org/licenses/by-nc-nd/4.0/ 4.0
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
Volume 26 Number 4| April 2020| 
26(4):14 
 
 
- 1 - 
Dermatology Online Journal  ||  Photo Vignette 
Unusual presentation of Kaposi sarcoma in an HIV-negative 
woman 
Allison L Limmer1 MD, Katherine E Park2 BS, Anisha B Patel1,3 MD, Auris O Huen3 MD 
Affiliations: 1The University of Texas McGovern Medical School, Houston, Texas, USA, 2Baylor College of Medicine, Houston, Texas, 
USA, 3The University of Texas MD Anderson Cancer Center, Houston, Texas, USA 
Corresponding Author: Auris O Huen, MD, 1515 Holcombe Boulevard, Unit 1452, Houston, TX 77030, Tel: 713-745-1113, Email: 
aohuen@mdanderson.org 
 
 
 
 
Keywords: Kaposi sarcoma, squamous cell carcinoma, HIV, 
treatment 
 
Introduction 
Kaposi sarcoma is a vascular neoplasm often 
presenting with red-purple macules and papules of 
the skin or mucus membranes in 
immunocompromised patients. Biopsy of such 
lesions classically demonstrates hypervascularity 
and spindle cells. Herein, we describe a woman in her 
70s with a past medical history significant for plaque 
psoriasis who presented with a new, scaling pink 
papule on her right posterior arm. On clinical 
examination, the lesion was concerning for 
squamous cell carcinoma (SCC) or SCC in situ, 
superficial basal cell carcinoma, or even an irritated 
actinic keratosis. A biopsy was performed and 
histopathology and immunohistochemical staining 
revealed findings consistent with Kaposi sarcoma. 
 
Case Synopsis 
A 74-year-old HIV-negative woman presented to the 
dermatology clinic for a new, hyperkeratotic, 1-
centimeter pink papule of the right posterior upper 
arm (Figure 1). The patient reported no pruritis or 
bleeding and was regularly followed by the 
dermatology department for a known history of 
plaque psoriasis. Supported by the clinical 
appearance and nonhealing nature, the lesion was 
biopsied secondary to concern for cancerous or 
precancerous lesions such as SCC or SCC in situ, 
Abstract 
Kaposi sarcoma typically presents as violaceous 
macules and papules in immunocompromised, 
specifically HIV-positive, patients. Its distinct clinical 
features often facilitate rapid diagnosis. In this article, 
we report a case of Kaposi sarcoma presenting as a 
concerning yet nondescript lesion in an HIV-negative 
woman. Although Kaposi sarcoma is frequently part 
of the differential diagnosis for skin lesions affecting 
HIV-positive patients, it is less frequently considered 
in HIV-negative individuals. Additionally, this case 
differs from the classic clinical presentation of Kaposi 
sarcoma by resembling a squamous cell carcinoma or 
superficial basal cell carcinoma. Therefore, it 
illustrates the importance of suspicious lesion 
biopsies to ensure accurate diagnosis and 
appropriate treatment. 
Figure 1. Hyperkeratotic, pink papule on the right posterior upper 
arm confirmed as Kaposi sarcoma by biopsy. 
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superficial basal cell carcinoma, or even an irritated 
actinic keratosis. 
On histopathology, numerous extravasated 
erythrocytes between fascicles of spindled cells were 
observed in the dermis (Figure 2A). The lesional cells 
were positive for human herpes virus (HHV)-8, 
consistent with a diagnosis of Kaposi sarcoma 
(Figure 2B). Routine laboratories confirmed HIV-
negative status and were positive only for mild 
anemia. The papule was successfully treated with 
localized radiation therapy with no evidence of 
recurrence on follow-up. During staging, the patient 
was found to have papillary urothelial carcinoma; 
she underwent resection and is currently receiving 
Calmette-Guerin injection therapy. Computed 
tomography (CT) demonstrated no other findings, 
including evidence of metastatic disease. 
 
Case Discussion 
Kaposi sarcoma (KS) classically presents as non-
blanching, violaceous macules and papules of the 
skin or mucous membranes of immuno-
compromised individuals, especially those with HIV. 
Although often clinically distinct, a biopsy of KS 
lesions is useful because the differential diagnosis for 
KS includes conditions such as bacillary 
angiomatosis, that are both treatable and readily 
distinguishable by pathologic analysis. Classic 
findings include dermal vascular and spindle cell 
proliferation, inflammation, and extravasated blood 
forming hyaline globules and hemosiderin 
deposition [1]. 
Management of KS includes reducing 
immunosuppression in HIV-associated KS by 
initiating highly active antiretroviral therapy (HAART) 
or limiting immunosuppressive agents in 
iatrogenically-derived KS. Treatment of acquired 
immunodeficiency syndrome (AIDS)-related KS is 
supported by extensive evidence and is based on 
disease staging. Beyond the setting of AIDS, Kaposi 
sarcoma is approached by clinical experience and 
brief reports, as high-quality evidence is lacking. 
AIDS-related KS therapies include liposomal 
anthracyclines, paclitaxel, combined bleomycin and 
vincristine, interferon alpha, alitretinoin, and 
radiation therapy. Smaller studies support the use of 
imatinib, bevacizumab, interleukin-12, 
immunomodulatory imide drugs, proteasome 
inhibitors, PI3K-AKT-TOR pathway inhibitors, and 
drugs such as timolol and propranolol that inhibit 
beta adrenergic receptor-mediated signaling [1]. 
Prior to the widespread use of HAART, KS was found 
in one of three HIV-positive men who have sex with 
men, compared to one in 100,000 in the general 
population [2]. However, the case presented here in 
which biopsy-confirmed Kaposi sarcoma resembling 
a concerning yet nondescript lesion was identified in 
an HIV-negative patient demonstrates how Kaposi 
 
Figure 2. Kaposi sarcoma. Histopathologic analysis of the biopsy 
specimen demonstrated extravasated erythrocytes interspersed 
between fascicles of spindled cells within the dermis A) on H&E at 
20×, B) as well as positive human herpes virus-8 immunostaining, 
20× 
A 
B 
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sarcoma can deviate from the classic clinical 
presentation. 
 
Conclusion 
Kaposi sarcoma is an important part of the 
differential diagnosis for skin lesions in HIV patients. 
Multiple cases have demonstrated that KS should 
not be ruled out, though, when HIV-negative 
patients present with suggestive clinical findings. 
The case detailed here reinforces that KS is not only 
a disease of HIV-positive individuals while also 
illustrating the importance of acquiring biopsies of 
suspicious lesions to ensure accurate diagnosis and 
appropriate treatment. 
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